Dai-ichi Life Group completed the payment for new shares issued under the stock compensation plan on July 13, 2026, and issued restricted stock and performance-linked stock.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"8750","jir_company_name":"Dai-ichi Life Group","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-07-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/8750-20260713-01.pdf","jir_short_summary":"Dai-ichi Life Group completed the payment for new shares issued under the stock compensation plan on July 13, 2026, and issued restricted stock and performance-linked stock.","jir_summary":"### Overview of Capital Policy\nDai-ichi Life Group issued new shares as part of its stock compensation plan based on a Board of Directors resolution on June 22, 2026, and completed the payment process. Two types of shares were issued: restricted stock and performance-linked stock, with respective share quantities and amounts publicly disclosed. This aims to incentivize officers and employees, although it may lead to stock dilution and capital costs.\n\n### Impact on Shareholders and Future Outlook\nWhile the issuance of new shares may cause stock dilution, the primary goal of the program is to enhance the performance of officers and employees and increase corporate value. The specific shareholding ratios and impact on shareholder value after payment completion will need to be monitored. Continued efforts to enhance shareholder returns and transparency in capital policy are expected.","jir_financial_highlights":"Number of Shares Issued: 269,800 shares (Restricted Stock) (Unknown)\nTotal Issuance Amount: 489,552,100 yen (Unknown)\nNumber of Performance-Linked Shares Issued: 473,000 shares (Unknown)","jir_category":"","jir_hashtags":"#DaiichiLifeGroup, #CapitalPolicy, #JapanStocks","jir_key_figures":"Number of shares issued (Restricted Stock): 269,800 shares\nNumber of shares issued (Performance-Linked): 473,000 shares\nTotal issuance amount: 1,814.5 yen per share (Total: Unknown)","jir_meta_title":"\u3010Dai-ichi Life Group\u3011Completion of Stock Issuance under the Stock Compensation Plan | July 2026","jir_meta_description":"Dai-ichi Life Group completed the payment for new shares issued under the stock compensation plan on July 13, 2026, and reports details of the scheme and its impact on shareholders.","jir_og_title":"\u3010Dai-ichi Life Group\u3011Completion of Stock Issuance under the Stock Compensation Plan | July 2026","jir_og_description":"Dai-ichi Life Group completed the issuance of new shares under the stock compensation plan in July 2026. Details of share quantities, amounts, and future outlook are explained.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6871,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-79952","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n